RSF1 overexpression was also recently correlated with pathological type, tumor aggressiveness, and TP53 status in breast cancer, such that the overall survival was shorter for breast cancer patients with tumors overexpressing RSF1 and harboring TP53 mutations14. The gene discussed is TP53; the disease is neoplasm.